Evidence map›Paper›PMID 41557122›Full record

ArticleOdontology2026

Evaluations of high-viscosity glass-ionomer cement modified by eucalyptus extract-loaded mesoporous silica nanoparticles: in vitro study.

Mai Samy Sheta, Zienab E Eldin

Abstract read
In one paragraph

Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mai Samy ShetaDental Biomaterials Department, Faculty of Dentistry, Tanta University, El-Giesh St., Tanta, Gharbia, Egypt. mai_sheta@dent.tanta.edu.eg.ORCID http://orcid.org/0009-0003-3828-9575
Zienab E EldinMaterials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Beni-Suef, 62511, Egypt.ORCID http://orcid.org/0009-0008-1427-3161

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glass-ionomer cements offer unique qualities, including bulk insertion, chemical adhesion to tooth tissues, fluoride release, as well as recharge. This study aimed to assess the effect of addition of eucalyptus extract-loaded mesoporous silica nanoparticles (EE@MSNs) to high-viscosity glass-ionomer cement HVGIC on its mechanical properties, antimicrobial activity, and fluoride release. EE@MSNs were prepared and characterized. Then, they were added to HVGIC Fuji IX at weight percentages of 1%, 3%, and 5% to create three experimental groups which were compared with the unmodified control group. Compressive strength, Vickers microhardness, and antimicrobial activity against Streptococcus mutans were evaluated. Fluoride release was assessed after 24 h and 7 days. HVGIC modified by 1% and 3% EE@MSNs recorded significant improvement in compressive strength and Vickers microhardness compared to control groups. While higher ratio 5% showed decline in the mechanical properties. Experimental groups recorded significant increase in antibacterial activity and fluoride release when compared to control group and this increase was proportional to EE@MSNs percentage. Addition of 1 and 3 wt.% EE@MSNs could be considered a promising approach to modify properties of HVGICs.

Indexed as

EucalyptusGlass Ionomer CementsNanoparticlesPlant ExtractsSilicon DioxideAnti-Bacterial AgentsCompressive StrengthFluoridesHardnessIn Vitro TechniquesMaterials TestingPorosityStreptococcus mutansViscosityAnti-Bacterial AgentsFluoridesfuji IXGlass Ionomer CementsPlant ExtractsSilicon DioxideAntimicrobial propertiesEucalyptus extractFluoride releaseHigh-viscosity glass-ionomer cementMechanical properties

Identifiers

PMID41557122
PMCPMC13631022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.